Literature DB >> 8100999

Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.

R T Gazzinelli1, S Hieny, T A Wynn, S Wolf, A Sher.   

Abstract

Immunity against the intracellular protozoan Toxoplasma gondii is highly dependent on interferon gamma (IFN-gamma). We have previously shown that, in addition to T lymphocytes, natural killer (NK) cells can be stimulated by the parasite to produce this cytokine by a reaction requiring adherent accessory cells and tumor necrosis factor alpha. We now demonstrate that a recently characterized cytokine, interleukin 12 (IL-12), is also necessary for parasite-induced IFN-gamma synthesis by NK cells. Anti-IL-12 antibodies completely inhibited T. gondii or bacterial endotoxin-stimulated IFN-gamma production by NK-enriched spleen cells from severe combined immunodeficient mice. Moreover, potent NK cytokine responses were induced by the combination of IL-12 and tumor necrosis factor alpha. In addition, adherent spleen cells from scid/scid mice or thyoglycollate-elicited macrophages from BALB/c animals produced high levels of both IL-12 (p40) and tumor necrosis factor alpha mRNAs when exposed to either live tachyzoites, parasite extracts, or endotoxin, confirming that these cytokines are produced by accessory cells. Finally, in vivo studies showed that treatment with recombinant IL-12 results in prolonged survival of scid mice after infection with T. gondii by means of a response dependent on both IFN-gamma and NK cells. Together the data argue that IL-12 is required for the T-cell-independent triggering of NK cells by intracellular parasites and that the cytokine may be useful for inducing this protective pathway in immunodeficient hosts.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8100999      PMCID: PMC46878          DOI: 10.1073/pnas.90.13.6115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Specific assays for cytokine production by T cells.

Authors:  T R Mosmann; T A Fong
Journal:  J Immunol Methods       Date:  1989-01-17       Impact factor: 2.303

2.  Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.

Authors:  R T Gazzinelli; F T Hakim; S Hieny; G M Shearer; A Sher
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

Review 3.  Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse.

Authors:  G J Bancroft; R D Schreiber; E R Unanue
Journal:  Immunol Rev       Date:  1991-12       Impact factor: 12.988

4.  The effect of anti-IFN-gamma antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice.

Authors:  Y Suzuki; J S Remington
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

5.  Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody.

Authors:  A Svetić; F D Finkelman; Y C Jian; C W Dieffenbach; D E Scott; K F McCarthy; A D Steinberg; W C Gause
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

6.  Pathophysiology of toxoplasmosis.

Authors:  J K Frenkel
Journal:  Parasitol Today       Date:  1988-10

7.  Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome.

Authors:  B J Luft; R G Brooks; F K Conley; R E McCabe; J S Remington
Journal:  JAMA       Date:  1984-08-17       Impact factor: 56.272

8.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

Authors:  M Kobayashi; L Fitz; M Ryan; R M Hewick; S C Clark; S Chan; R Loudon; F Sherman; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

9.  Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.

Authors:  J Chehimi; S E Starr; I Frank; M Rengaraju; S J Jackson; C Llanes; M Kobayashi; B Perussia; D Young; E Nickbarg
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

10.  Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.

Authors:  A D'Andrea; M Rengaraju; N M Valiante; J Chehimi; M Kubin; M Aste; S H Chan; M Kobayashi; D Young; E Nickbarg
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  279 in total

Review 1.  IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses.

Authors:  G Haskó; C Szabó
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Exaggerated proinflammatory and Th1 responses in the absence of gamma/delta T cells after infection with Listeria monocytogenes.

Authors:  M J Skeen; E P Rix; M M Freeman; H K Ziegler
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 3.  Monocytes mediate mucosal immunity to Toxoplasma gondii.

Authors:  Ildiko R Dunay; L David Sibley
Journal:  Curr Opin Immunol       Date:  2010-05-27       Impact factor: 7.486

4.  Mechanism of entry determines the ability of Toxoplasma gondii to inhibit macrophage proinflammatory cytokine production.

Authors:  Barbara A Butcher; Eric Y Denkers
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

Review 5.  Costimulation in resistance to infection and development of immune pathology: lessons from toxoplasma.

Authors:  Christopher A Hunter; Linda A Lieberman; Nicola Mason; Marion Pepper; Sarah L Sague; Cristina Tato; Valerie Zediak
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

6.  Long-term protective immune response elicited by vaccination with an expression genomic library of Toxoplasma gondii.

Authors:  Alberto Fachado; Alexandro Rodriguez; Judith Molina; Jaline C Silvério; Ana P M P Marino; Luzia M O Pinto; Sergio O Angel; Juan F Infante; Yara Traub-Cseko; Regina R Amendoeira; Joseli Lannes-Vieira
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

Review 7.  An inside job: hacking into Janus kinase/signal transducer and activator of transcription signaling cascades by the intracellular protozoan Toxoplasma gondii.

Authors:  Eric Y Denkers; David J Bzik; Barbara A Fox; Barbara A Butcher
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

8.  Toxoplasma gondii cyclophilin 18 regulates the proliferation and migration of murine macrophages and spleen cells.

Authors:  Hany M Ibrahim; Xuenan Xuan; Yoshifumi Nishikawa
Journal:  Clin Vaccine Immunol       Date:  2010-07-21

9.  Flt3 Ligand Is Essential for Survival and Protective Immune Responses during Toxoplasmosis.

Authors:  Christopher D Dupont; Gretchen Harms Pritchard; Shinya Hidano; David A Christian; Sagie Wagage; Gaia Muallem; Elia D Tait Wojno; Christopher A Hunter
Journal:  J Immunol       Date:  2015-09-18       Impact factor: 5.422

10.  Toxoplasma gondii soluble antigen induces a subset of lipopolysaccharide-inducible genes and tyrosine phosphoproteins in peritoneal macrophages.

Authors:  Z Y Li; C L Manthey; P Y Perera; A Sher; S N Vogel
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.